Journal of Experimental Medicine, Vol 178, 743-747, Copyright © 1993 by Rockefeller University Press

ARTICLES

Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro

LJ Montaner, AG Doyle, M Collin, G Herbein, P Illei, W James, A Minty, D Caput, P Ferrara and S Gordon
Sir William Dunn School of Pathology, University of Oxford, United Kingdom.

The mechanisms by which cellular immunity maintains the asymptomatic state after human immunodeficiency virus type 1 (HIV-1) infection are poorly understood. CD4+ T lymphocytes play a complex role in regulating anti-HIV effector pathways, including activation of macrophages, which are themselves implicated in clinical latency and pathogenesis of symptomatic acquired immune deficiency syndrome. We have found that a newly identified T helper type 2 lymphokine, interleukin 13 (IL-13), inhibits HIV-1ADA and Ba-L replication in primary tissue culture- derived macrophages but not in peripheral blood lymphocytes. Viral production in cells was measured by viral protein (p24) and reverse transcriptase levels, while entry was assessed by proviral DNA analysis at timed intervals after infection. Inhibition by IL-13 was dose and time dependent and not mediated through altered viral entry, reverse transcription, or viral release. IL-13 is therefore a candidate cytokine for the suppression of HIV infection within monocytes and macrophages in vivo.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Papasavvas, E., Sun, J., Luo, Q., Moore, E. C., Thiel, B., MacGregor, R. R., Minty, A., Mounzer, K., Kostman, J. R., Montaner, L. J. (2005). IL-13 Acutely Augments HIV-Specific and Recall Responses from HIV-1-Infected Subjects In Vitro by Modulating Monocytes. J. Immunol. 175: 5532-5540 [Abstract] [Full Text]  
• Perez-Bercoff, D., David, A., Sudry, H., Barre-Sinoussi, F., Pancino, G. (2003). Fc{gamma} Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages. J. Virol. 77: 4081-4094 [Abstract] [Full Text]  
• Zidek, Z., Frankova, D., Holy, A. (2001). Activation by 9-(R)-[2-(Phosphonomethoxy)Propyl]Adenine of Chemokine (RANTES, Macrophage Inflammatory Protein 1alpha ) and Cytokine (Tumor Necrosis Factor Alpha, Interleukin-10 [IL-10], IL-1beta ) Production. Antimicrob. Agents Chemother. 45: 3381-3386 [Abstract] [Full Text]  
• Geiben-Lynn, R., Kursar, M., Brown, N. V., Kerr, E. L., Luster, A. D., Walker, B. D. (2001). Noncytolytic Inhibition of X4 Virus by Bulk CD8+ Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Persons and HIV-1-Specific Cytotoxic T Lymphocytes Is Not Mediated by {beta}-Chemokines. J. Virol. 75: 8306-8316 [Abstract] [Full Text]  
• Husain, S. R., Puri, R. K. (2000). Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft. Blood 95: 3506-3513 [Abstract] [Full Text]  
• Bailer, R. T., Holloway, A., Sun, J., Margolick, J. B., Martin, M., Kostman, J., Montaner, L. J. (1999). IL-13 and IFN-{gamma} Secretion by Activated T Cells in HIV-1 Infection Associated with Viral Suppression and a Lack of Disease Progression. J. Immunol. 162: 7534-7542 [Abstract] [Full Text]  
• Montaner, L. J., da Silva, R. P., Sun, J., Sutterwala, S., Hollinshead, M., Vaux, D., Gordon, S. (1999). Type 1 and Type 2 Cytokine Regulation of Macrophage Endocytosis: Differential Activation by IL-4/IL-13 as Opposed to IFN-{gamma} or IL-10. J. Immunol. 162: 4606-4613 [Abstract] [Full Text]  
• Lai, Y. H., Mosmann, T. R. (1999). Mouse IL-13 Enhances Antibody Production In Vivo and Acts Directly on B Cells In Vitro to Increase Survival and Hence Antibody Production. J. Immunol. 162: 78-87 [Abstract] [Full Text]  
• Manna, S. K., Aggarwal, B. B. (1998). IL-13 Suppresses TNF-Induced Activation of Nuclear Factor-{kappa}B, Activation Protein-1, and Apoptosis. J. Immunol. 161: 2863-2872 [Abstract] [Full Text]  
• Wang, J., Roderiquez, G., Oravecz, T., Norcross, M. A. (1998). Cytokine Regulation of Human Immunodeficiency Virus Type 1 Entry and Replication in Human Monocytes/Macrophages through Modulation of CCR5 Expression. J. Virol. 72: 7642-7647 [Abstract] [Full Text]  
• Hatch, W. C., Freedman, A. R., Boldt-Houle, D. M., Groopman, J. E., Terwilliger, E. F. (1997). Differential Effects of Interleukin-13 on Cytomegalovirus and Human Immunodeficiency Virus Infection in Human Alveolar Macrophages. Blood 89: 3443-3450 [Abstract] [Full Text]  
• Wong, M.-L., Bongiorno, P. B., Rettori, V., McCann, S. M., Licinio, J. (1997). Interleukin (IL) 1beta , IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications. Proc. Natl. Acad. Sci. USA 94: 227-232 [Abstract] [Full Text]  
• Moriuchi, H., Moriuchi, M., Combadiere, C., Murphy, P. M., Fauci, A. S. (1996). CD8+ T-cell-derived soluble factor(s), but not beta -chemokines RANTES, MIP-1alpha , and MIP-1beta , suppress HIV-1 replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA 93: 15341-15345 [Abstract] [Full Text]  
• Sozzani, P., Cambon, C., Vita, N., Séguélas, M.-Hélèn., Caput, D., Ferrara, P., Pipy, B. (1995). Interleukin-13 Inhibits Protein Kinase C-triggered Respiratory Burst in Human Monocytes. J. Biol. Chem. 270: 5084-5088 [Abstract] [Full Text]  
• Vita, N., Lefort, S., Laurent, P., Caput, D., Ferrara, P. (1995). Characterization and Comparison of the Interleukin 13 Receptor with the Interleukin 4 Receptor on Several Cell Types. J. Biol. Chem. 270: 3512-3517 [Abstract] [Full Text]  
• Montaner, L., Gordon, S (1995). TH2 downregulation of macrophage HIV-1 replication. Science 267: 538-539  
• Fauci, A. (1993). Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262: 1011-1018 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS